会社概要
- 正式社名: ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD
- 登録国: China
- 住所: No. 9,Weiyi Road, Hangzhouwan Economic Techchnology Development Zone, Shangyu District, Shaoxing
- 従業員数: 100 - 249
説明:
This is a new, innovative, green, high-grade pharmaceutical API producer established in 2020, covering an area of nearly 66,000 square meters with 50,000 square meters of plant area. The company produces Gabapentin, Benzocaine, Pregabalin, Tranexamic Acid and Levocarnitine, along with the food additive Dimethyl Dicarbonate, with each API holding US DMF, CEP certification and Written Confirmation.
事業活動
原薬(API)
原薬メーカー
天然抽出物・生薬原料
原薬メーカー
バイオ医薬品
原薬メーカー
先発品原薬
原薬メーカー
販売市場
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia
- Western Europe: Austria, Belgium, France, Germany, Luxembourg, Netherlands
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon
当社の製品・サービス
Sell · Active Pharmaceutical Ingredients (APIs)
認証
GMP
ISO
証明
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す